Apollomics

Apollomics Current Ratio

The Current Ratio of Apollomics (APLM) as of Oct 17, 2026 is 0.56. In the previous year, Current Ratio was 1.37 — a change of -58.92% (lower).

Current Ratio

0.56

YoY

-58.92%

Last updated:

Current Ratio of Apollomics is 2025 0.56 . Current Ratio of Apollomics was 2024 1.37 . It decreases by -58.92% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apollomics Stock analysis

What does Apollomics do? Apollomics Inc is a clinical-stage biotechnology company based in Foster City, California, operating within the Health Care sector. The company went public via an IPO on November 26, 2021, and is listed under the ticker APLM with ISIN KYG0411D1236. Apollomics focuses on the discovery and development of oncology therapies designed to address unmet medical needs. The company's pipeline includes approximately nine drug candidates, six of which are in clinical development. Its lead program involves vebreltinib (APL-101), a c-Met inhibitor being evaluated in a Phase II multicohort clinical trial for non-small cell lung cancer and other advanced tumors with c-Met alterations. Another key candidate is uproleselan (APL-106), an E-Selectin antagonist under development as an adjunct to standard chemotherapy for acute myeloid leukemia and other hematologic cancers. Apollomics aims to create therapies that can be combined with existing treatments to enhance immune system engagement and target specific molecular pathways in cancer. The company's website is www.apollomicsinc.com. Apollomics is engaged in advancing innovative oncology treatments through clinical research and development. Apollomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apollomics stock

Current Ratio of Apollomics is 0.56 in 2025.

Current Ratio of Apollomics changed from 1.37 to 0.56, representing a -58.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Apollomics since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Apollomics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Apollomics

All Key Metrics — Apollomics